IN8bio to Present at International Society for Cell & Gene Therapy (ISCT) 2024

NEW YORK, May 24, 2024 (GLOBE NEWSWIRE) -- IN8bio, Inc. (NASDAQ:INAB) a clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced multiple presentations at the International Society for Cell & Gene Therapy 2024, to be held May 28th to June 1st in Vancouver, Canada. "ISCT is a scientific gathering renowned for fostering groundbreaking ideas and innovation in cellular therapies," said Dr. Kate Rochlin, Chief Operating Officer of IN8bio. "Our presentations rep ...